Stocks-JAGX-Jaguar Health Inc

JAGX Jaguar Health Inc

0.1300 0 (0%)
Invest
Invest

Overview

Prev Close0.1300
Day's Range 0.1075 - 0.1318
52 Week Range 0.0950 - 1.86
Average Volume (3m)3.07M
1-Year Return-91.45%
Beta0.792
Market Cap18.88M
P/E Ratio
Revenue10.78M
EPS-0.9211
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.721/06/202201/09/202211/11/20220.10000.15000.20000.25000.30000.35000.4000
Chart times in UTC
Industry Pharmaceuticals Major
CEO Lisa A. Conte, MBA
Employees 52

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Jaguar Health Inc's revenues decreased by 53.81% and amounted to 4.34M. Net income decreased by 55.58% to -52.60M. Net assets decreased by 31.10% to 11.85M and EPS decreased from -1.00 to -1.18.
JAGX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
68.99%
Net Profit Margin
-694.50%
Operating Margin
-467.35%
Return On Investment
-147.77%
12/21
03/22
06/22
09/22
Total Revenue
2.08M
2.63M
2.92M
3.15M
Gross Profit
1.37M
1.72M
1.82M
2.54M
Operating Income
-10.82M
-11.75M
-6.48M
-9.9M
Net Income
-14.32M
-18.16M
-9.39M
-12.61M